Found 46 matching trials
Immunotherapy With Neo-adjuvant Chemotherapy for OVarian Cancer PHASE1 This is a randomized, open, comparative, multi-centre study which will recr...
Show More Location
Institut Ste Catherine
Learn More & Join Trial
An uMbrella Study of BIomarker-driven Targeted Therapy In Patients With Platinum-resistant Recurrent OvariaN Cancer(AMBITION) PHASE2 This study is a pilot study of biomarker-driven targeted therapy in patient...
Show More Location
Seoul National University Hospital
Learn More & Join Trial
Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid Tumors PHASE1 Durvalumab and Tremelimumab in combination with first-line chemotherapy in ...
Show More Learn More & Join Trial
Study of Durvalumab + Tremelimumab With Chemotherapy or Durvalumab With Chemotherapy or Chemotherapy Alone for Patients With Lung Cancer (POSEIDON). PHASE3 This is a randomized, open-label, multi-center, global, Phase III study to ...
Show More Status
Active Not Recruiting
Learn More & Join Trial
Neo-adjuvant Chemo and Immunotherapy in the Pre-operAtive Treatment of Locally Advanced CholangIOcarciNoma PHASE2 Neoadjuvant chemo- and immunotherapy ameliorate the recurrence rate of chol...
Show More Location
Istituto Nazionale Tumori di Napoli - IRCCS - Fondazione G. Pascale
Learn More & Join Trial
HAIC Combined With Durvalumab and Tremelimumab and Lenvatinib in uHCC PHASE2 The treatment options for unresectable HCC have rapidly developed, and immu...
Show More Location
Hunan Provincial People's Hospital(The First Affiliated Hospital of Hunan Normal University)
Learn More & Join Trial
Randomized Phase II, Open-label Efficacy and Safety Study of Second-line Durvalumab Plus Tremelimumab Versus Platinum-based Chemotherapy Alone in Patients With NSCLC and First-line Checkpoint-inhibitor Therapy (Re-Check) PHASE2 This is an open label, randomized, Phase II multicenter study designed to e...
Show More Location
Asklepios Fachkliniken München-Gauting
Learn More & Join Trial
Neoadjuvant MEDI4736 Concomitant With Weekly Nab-paclitaxel and Dose-dense AC for Stage I-III Triple Negative Breast Cancer PHASE1 The purpose of the study is to address the following hypotheses: (i) Anti-P...
Show More Location
Yale School of Medicine
Learn More & Join Trial
Radiation Therapy and Durvalumab, With or Without Tremelimumab, in Patients With Bladder Cancer PHASE2 This is a multi-site, randomized, prospective, open-label phase II study. P...
Show More Location
UCSF Helen Diller Family Comprehensive Cancer Center
Learn More & Join Trial
Microbiome Immunotherapy Toxicity and Response Evaluation N/A This is a observational study to investigate how the microbiome correlates ...
Show More Location
Royal United Hospitals Bath NHS Foundation Trust
Learn More & Join Trial